ebomi
Colour theme
Sign in
Insider · CIK 0001460751

NEA 13 GP, Ltd

CIK 0001460751 Name as filed on the most recent filing

Filed as NEA 13 GP, Ltd (27)

47 transaction lines · from 27 filings · filed 2011-11-22 to 2025-03-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-03-14 S, Open-market sale BuzzFeed, Inc.BZFD 618,383, disposed Open Form 4 filing 0000950170-25-039628
2025-03-13 S, Open-market sale BuzzFeed, Inc.BZFD 123,769, disposed Open Form 4 filing 0000950170-25-039628
2025-03-12 S, Open-market sale BuzzFeed, Inc.BZFD 55,854, disposed Open Form 4 filing 0000950170-25-039628
2025-03-11 S, Open-market sale BuzzFeed, Inc.BZFD 26,620, disposed Open Form 4 filing 0000950170-25-037454
2025-03-07 S, Open-market sale BuzzFeed, Inc.BZFD 69,602, disposed Open Form 4 filing 0000950170-25-037454
2025-03-06 S, Open-market sale BuzzFeed, Inc.BZFD 23,372, disposed Open Form 4 filing 0000950170-25-035077
2025-03-05 S, Open-market sale BuzzFeed, Inc.BZFD 18,266, disposed Open Form 4 filing 0000950170-25-035077
2025-03-04 S, Open-market sale BuzzFeed, Inc.BZFD 2,978, disposed Open Form 4 filing 0000950170-25-035077
2023-07-18 S, Open-market sale Sagimet Biosciences Inc.SGMT 10,592, disposed Open Form 4 filing 0001209191-23-042970
2023-07-18 P, Open-market purchase Sagimet Biosciences Inc.SGMT 480,000, acquired Open Form 4 filing 0001209191-23-042970
2023-02-09 P, Open-market purchase Minerva Surgical IncUTRS 5,000,000, acquired Open Form 4 filing 0001209191-23-008574
2022-10-25 S, Open-market sale PhaseBio Pharmaceuticals IncPHAS 262,264, disposed Open Form 4 filing 0001209191-22-054647
2021-10-26 P, Open-market purchase Minerva Surgical IncUTRS 15,600,000, acquired Open Form 4 filing 0001209191-21-061994
2020-08-17 S, Open-market sale Sprout Social, Inc.SPT 2 lines 94,650,765, disposed Open Form 4 filing 0001209191-20-047101
2018-12-14 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 9,999,996, acquired Open Form 4 filing 0001209191-18-062803
2018-10-22 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 9,000,000, acquired Open Form 4 filing 0001209191-18-056072
2018-03-06 P, Open-market purchase Tesaro, Inc.TSRO 755,708, acquired Open Form 4 filing 0001209191-18-017562
2018-03-05 P, Open-market purchase Tesaro, Inc.TSRO 3 lines 2,892,600, acquired Open Form 4 filing 0001209191-18-017562
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 4 lines 3,036,169, acquired Open Form 4 filing 0001209191-18-017562
2018-02-16 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 12,000,000, acquired Open Form 4 filing 0001209191-18-011903
2017-10-10 P, Open-market purchase Rhythm Pharmaceuticals, Inc.RYTM 9,350,000, acquired Open Form 4 filing 0001209191-17-056453
2016-10-31 S, Open-market sale Ra Pharmaceuticals, Inc.RARX 5,655, disposed Open Form 4 filing 0001209191-16-147480
2016-10-31 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 4,400,006, acquired Open Form 4 filing 0001209191-16-147480
2016-03-18 P, Open-market purchase Tesaro, Inc.TSRO 24,999,997, acquired Open Form 4 filing 0001209191-16-109537
2016-01-12 P, Open-market purchase Epizyme, Inc.EPZM 9,999,999, acquired Open Form 4 filing 0001209191-16-091059
2014-10-08 P, Open-market purchase Dermira, Inc.DERM 1,105,792, acquired Open Form 4 filing 0001181431-14-034002
2014-07-22 P, Open-market purchase Roka BioScience, Inc.ROKA 4,599,996, acquired Open Form 4 filing 0001181431-14-027151
2014-01-21 S, Open-market sale Cvent IncCVT 6,030,989, disposed Open Form 4 filing 0001181431-14-003480
2014-01-16 S, Open-market sale Cvent IncCVT 40,206,910, disposed Open Form 4 filing 0001181431-14-003123
2014-01-15 P, Open-market purchase Glycomimetics IncGLYC 4,100,000, acquired Open Form 4 filing 0001181431-14-002531
2013-11-15 P, Open-market purchase Epizyme, Inc.EPZM 2 lines 979,454, acquired Open Form 4 filing 0001181431-13-059373
2013-11-14 P, Open-market purchase Epizyme, Inc.EPZM 3 lines 7,018,527, acquired Open Form 4 filing 0001181431-13-059373
2013-06-05 P, Open-market purchase Epizyme, Inc.EPZM 6,000,000, acquired Open Form 4 filing 0001181431-13-033511
2013-04-16 S, Open-market sale Omthera Pharmaceuticals, Inc.OMTH 1,568, disposed Open Form 4 filing 0001181431-13-022601
2013-04-16 P, Open-market purchase Omthera Pharmaceuticals, Inc.OMTH 5,000,000, acquired Open Form 4 filing 0001181431-13-022601
2012-10-29 S, Open-market sale Millennial Media Inc.MM 21,478,252, disposed Open Form 4 filing 0001181431-12-055843
2012-07-03 P, Open-market purchase Tesaro, Inc.TSRO 14,999,999, acquired Open Form 4 filing 0001181431-12-039183
2011-11-21 P, Open-market purchase Clovis Oncology, Inc.CLVS 17,111,887, acquired Open Form 4 filing 0001181431-11-057256

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. NEA 13 GP, Ltd, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001460751

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.